Omar Kahaly

ORCID: 0000-0003-0690-4134
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Vascular anomalies and interventions
  • Cardiac Structural Anomalies and Repair
  • Cardiac Imaging and Diagnostics
  • Cardiac Health and Mental Health
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac Valve Diseases and Treatments
  • Mechanical Circulatory Support Devices
  • Advanced MRI Techniques and Applications
  • Systemic Sclerosis and Related Diseases
  • Kawasaki Disease and Coronary Complications
  • Cardiomyopathy and Myosin Studies
  • Connective Tissue Growth Factor Research
  • Electrospun Nanofibers in Biomedical Applications
  • Cardiovascular Function and Risk Factors
  • Coronary Artery Anomalies
  • Mast cells and histamine
  • Health Systems, Economic Evaluations, Quality of Life
  • Coronary Interventions and Diagnostics
  • Cardiac tumors and thrombi

ProMedica Toledo Hospital
2022-2025

University of Toledo
2023

The Ohio State University Wexner Medical Center
2016-2020

The Ohio State University
2017-2020

University of Toledo Medical Center
2012

Abstract Background Atrial fibrillation (AF) poses significant risks of stroke and mortality. Catheter ablation (CA) has emerged as a superior rhythm control strategy compared to medical therapy, but its long-term benefits in AF, ischemic prevention, remain underexplored. Methods This observational study analyzed data from the TriNetX Research Network, encompassing over 115 million patients. Adults diagnosed with paroxysmal atrial (PAF) between 2012 2019 were stratified into CA non-CA...

10.1093/ehjqcco/qcaf020 article EN European Heart Journal - Quality of Care and Clinical Outcomes 2025-04-16

Background Atrial fibrillation (AF) driver mechanisms are obscured to clinical multielectrode mapping approaches that provide partial, surface-only visualization of unstable 3-dimensional atrial conduction. We hypothesized transient modulation refractoriness by pharmacologic challenge during improves hidden paths reentrant AF drivers for targeted ablation. Methods and Results Pharmacologic with adenosine was tested in ex vivo human hearts a history cardiac diseases high-resolution subsurface...

10.1161/jaha.120.017789 article EN cc-by-nc-nd Journal of the American Heart Association 2020-10-02

High-risk candidates for percutaneous coronary intervention (PCI) may include patients with severe multi-vessel artery disease, unprotected left main stenosis, or last patent conduit a especially in ventricular (LV) ejection fraction of ≤35% (1-4). In addition, the condition and co-morbidities patient should be taken into consideration. Traditionally, revascularization these could better accomplished bypass graft (CABG) surgery; however, sometimes are high-risk surgical candidates, have...

10.21037/jtd.2016.01.77 article EN Journal of Thoracic Disease 2016-03-01

A coronary artery fistula (CAF) is an abnormal communication between a and cardiac chamber or great vessel. CAFs are rare based on arteriography when found they most often empty into the right ventricle atrium less high pressure, low compliance left (LV). patient who presented with atypical chest pain was to have multiple small originating from ramus intermedius emptying LV presented. This case highlights challenges in providing appropriate therapy for LV.

10.1155/2016/2406250 article EN cc-by Case Reports in Medicine 2016-01-01

A 76-year-old man presented for electrophysiologic evaluation of a temporary pacemaker wire detected in his aorta. His medical history included coronary artery disease, 2-vessel bypass grafting (CABG) 16 years previously, congestive heart failure (left ventricular ejection fraction, 0.35–0.40), hyperlipidemia, hypertension, frequent premature contractions, and single-chamber implantable cardioverter-defibrillator placement. primary care physician had ordered chest computed tomograms to...

10.14503/thij-17-6507 article EN Texas Heart Institute Journal 2020-06-01

Implanted cardioverter-defibrillators can prevent sudden cardiac death in at-risk patients. In comparison with conventional transvenous systems, entirely subcutaneous implantable have produced similar reductions the rate of but fewer sequelae. An infrequently reported drawback devices, however, is potential for generating attenuation artifact during nuclear myocardial perfusion imaging. We had concerns about a 65-year-old man coronary artery disease found that having positioned pulse...

10.14503/thij-16-5921 article EN Texas Heart Institute Journal 2017-06-01

Background: Overnight call can lead to sleep deprivation and fatigue. It was hypothesized that complications will increase when coronary artery procedures are performed the day after overnight (i.e. post-call). The present study undertaken test this hypothesis. Methods: From June 2009 May 2013, >20,000 patients underwent a cardiac procedure in large referral catheterization laboratory of which 10,190 (12.7%, n=1,298 post-call) only arteriography with (37%) or without (83%) percutaneous...

10.1161/circoutcomes.10.suppl_3.236 article EN Circulation Cardiovascular Quality and Outcomes 2017-03-01

Background: Implantable cardioverter-defibrillator (ICD) therapy prevents sudden cardiac death in selected patients with heart failure. When a primary prevention ICD arrives at elective replacement interval (ERI), conventional management is to replace the device. However, effectiveness of ICDs nonischemic and ischemic cardiomyopathy (NICM ICM, respectively) whose left ventricular ejection fraction (LVEF) improved ≥50% before unclear. Hypothesis: The therapeutic benefit for NICM attenuated by...

10.1161/circ.142.suppl_3.13843 article EN Circulation 2020-11-17
Coming Soon ...